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Introduction
Tumor invasion and metastasis remain principal causes for the resultant mortality of patients with cancer, including triplenegative breast cancer (TNBC). 1 TNBC is a subtype of breast cancer characterized by its high aggressiveness. Patients with TNBC tend to have distant metastasis and a very poor prognosis due to the lack of efficient targeted therapies. 2 A recent study has shown that microvesicles (MVs) shed from the surface of cancer cells are crucial for the invasion and metastasis of cancer cells. 3 The tumor-derived MVs can act as messengers to transfer bioactive lipids and proteins, including oncogene products and receptors, from the origin cells to recipient ones in distal sites during the process of metastasis.
3 Indeed, the MVs derived from TNBC have been shown to promote tumor invasion and metastasis. 4 Thereby, a novel strategy to inhibit or minimize the generation of MVs in TNBC may be valuable for the prevention and treatment of TNBC metastasis. However, unfortunately, there has been no application of a strategy to ght TNBC until now.
Nitric oxide (NO) is a gaseous signalling molecule and can modulate the epigenetic behavior of cells. 5 Several classes of NO donors inhibit the invasive activity of primary cancer cells by regulation of metalloproteinase (MMP), 6 N-myc downstreamregulated gene-1 (NDRG1) 7 and others in cancer cells. Additionally, some NO donors, such as CAP-NO (S-nitrosocaptoprilnin), prevent hetero-adhesion of cancer cells to vascular endothelial cells by down-regulating the expression of cell adhesion molecules (CAMs) onto the endothelial cells. Hence, inhibition of TNBC cell-derived MVs through an NObased epigenetic mechanism could suppress both the invasion and metastasis of TNBC. O 2 -Protected diazeniumdiolates have unique advantages because a rationally designed protecting group in diazeniumdiolates can be metabolically removed by enzyme(s) highly expressed in cancer cells, to selectively release high levels of NO, 9 which can induce apoptosis, and retard the proliferation and metastatic cascades.
10
Lysyloxidase (LOX) is a secreted primary amine oxidase and frequently over-expressed in cancer cells, particularly for those with a highly invasive potential, such as TNBC cells.
11-13 LOX expression is associated with poor overall survival in breast cancer patients.
14 A previous study has revealed that LOX is able to convert the 3-amino group of hydroxylysine and its derivatives into an aldehyde through an oxidative deamination process, accompanied by the production of hydrogen peroxide. Accordingly, we hypothesized that O 2 -(3-aminopropyl) diazeniumdiolates 3a-f could be metabolized by LOX to generate three toxic molecules, i.e. hydrogen peroxide, acrolein and diazeniumdiolate in TNBC cells via an oxidative deamination/belimination process (Fig. 1a) , and the diazeniumdiolate would subsequently release NO in situ to attenuate the metastasis of TNBC by inhibiting MV formation, and that the NO along with hydrogen peroxide and acrolein may synergistically exert potent anticancer activity.
Results and discussion
To test the hypothesis, we rstly designed and synthesized compounds 3a-f. The synthetic route to 3a-f is depicted in Fig. 1b . Six secondary amines were allowed to react with NO gas at high pressure (50 psi) in the presence of 30% sodium methoxide in methanol at room temperature as previously reported 15 to generate diazeniumdiolate sodium salts 1a-f. The condensation of 1a-f with N-Boc-3-bromopropylamine in a mixed solvent of THF and DMF in the presence of 15-crown-5 gave N-protected O 2 -(3-aminopropyl)diazeniumdiolates 2a-f, which were subsequently deprotected in boiling water to provide target compounds 3a-f, respectively. Next, we examined the anti-proliferative activity of 3a-f by MTT. Treatment with these compounds signicantly inhibited the proliferation of TNBC MDA-MB-231, MDA-MB-436 and MDA-MB-468 cells as well as melanoma B16F10, glioma U251 and prostate PC-3 cells, which express relatively high levels of LOX. Among them, 3f was the most potent (IC 50 ¼ 0.68-0.98 mM) against these TNBC cells, especially for MDA-MB-231 cells (0.68 AE 0.10 mM), and was superior to positive control cisplatin (Tables S1 and S2, and Fig. S1 -S3 ‡). Notably, 3f had 27-30 fold less inhibitory activity against poorly invasive breast cancer MCF-7 cells and non-tumor MCF10A cells that had lower levels of LOX expression than highly invasive/metastatic TNBC MDA-MB-231 cells ( Fig. S1 and S2, and Table S2 ‡), suggesting that 3f may selectively inhibit the proliferation of TNBC cells.
The stability of 3f in the absence or presence of LOX was examined by HPLC and Griess assays, 16 respectively. There was no detectable NO from 3f cultured in a PBS buffer (pH ¼ 7.4) and rat plasma for 7 h (Fig. S4 ‡) , whereas nearly 50% of the 3f was rapidly metabolized into NO upon addition of LOX for 120 min (Fig. 2a) . Actually, 3f released relatively high levels of NO in MDA-MB-231 cells but a little NO in MCF-7 and MCF10A cells ( Fig. 2b and S5 ‡). Furthermore, pretreatment with an LOX inhibitor, 17 b-aminopropionitrile (BAPN) potently diminished the amount of NO produced by 3f (Fig. S6b ‡) . In addition, 3f generated moderate levels of acrolein and hydrogen peroxide (Fig. S8 , ‡ 2c and d) in MDA-MB-231 cells, which were mitigated by pre-treatment with BAPN. Collectively, such data indicated that 3f was metabolized by LOX to produce NO, acrolein and hydrogen peroxide in TNBC cells.
Interestingly, 3f more potently inhibited the proliferation of MDA-MB-231 cells than the NO releasing moiety 1f as well as H 2 O 2 and acrolein alone or any two or three of them in combination at equimolar dose (Table S3 ‡) . In contrast, 3f displayed 20-and 14-fold less inhibitory activity than H 2 O 2 , acrolein and 1f in combination at equimolar dose on MCF-7 cells and MCF10A cells with relatively low levels of LOX expression, respectively (Table S4 ‡) . Moreover, pre-treatment with BAPN, carboxy-PTIO (an NO scavenger), 18 or N-acetylcysteine (NAC, a ROS scavenger) 19 substantially mitigated the antiproliferative activity of 3f (Fig. S9, ‡ 3a and 3b) . These results suggest that the inhibitory activity of 3f might be attributable to the synergistic effects of the three toxic molecules. It is known that NO can react rapidly with superoxide to form peroxynitrite, which acts as an inducer of cytotoxicity and apoptosis. 20 Thus, the potency of 3f may also be attributed, at least in part, to the contribution of peroxynitrite. In addition, the IC 50 value of 1f on MDA-MB-231 (5.18 mM) was signicantly lower than that of H 2 O 2 (26.01 mM) or acrolein (13.25 mM) (Table S3 ‡). And the amounts of NO released intracellularly were quite well associated with the antiproliferative activity of 3a-f, and the most active compound 3f released the highest levels of NO (Fig. S6a ‡) . These results suggest that the contribution of NO may be the most important among the three toxic molecules.
Given that the adhesion of tumor cells to vascular endothelial cells is crucial for effective invasion and metastasis, 21 we tested the effects of 3f on the adhesion of MDA-MB-231 cells to human umbilical vein endothelial cells (HUVECs) by the uo-rescence assay. MDA-MB-231 cells were stained with Rhodamine 123 and co-cultured for 1 h on conuent HUVECs that had been pre-treated with IL-1b 22 for 4 h and aer being washed, the adhered cells were counted under a uorescence microscope. Treatment with 3f signicantly inhibited the IL-1b-induced adhesion of MDA-MB-231 cells to HUVECs (Fig. 4a) . We also observed that treatment with 3f attenuated the TGF-b-induced 23 migration (Fig. 4b), invasion (Fig. 4c ) and lateral migration (Fig. 4d) of MDA-MB-231 cells in a dose-dependent manner (Fig. S10 ‡) . Thus, 3f inhibited the migration and invasion of TNBC cells in vitro.
Acute toxicity assays revealed that following intravenous treatment with 3f, the LD 50 value of 3f was 147.20 mg kg À1 in BALB/c nude mice throughout the 14 day observation (Table S5 and Fig. S11 ‡) . To evaluate the in vivo anti-TNBC efficacy of 3f, individual BALB/c nude mice were inoculated subcutaneously with MDA-MB-231 cells. Aer the establishment of solid tumors, the mice were randomized and treated intravenously with the vehicle (saline) or 3f at 2, 4, or 8 mg kg À1 every other day for 21 consecutive days. Compared with the vehicle control, treatment with 3f markedly inhibited the tumour growth and reduced the tumor volumes and weights in a dose-dependent manner (Fig. 5a-c) . Signicantly, treatment with 3f at 8 mg kg À1 inhibited the tumour growth by 76.2% (w/w) and did not affect the survival and body weights in mice (Fig. 5d) . Hence, 3f was a relatively safe compound and effectively inhibited the growth of TNBC in vivo.
We next determined the effect of 3f on the lung metastasis (a common location of distant metastasis) of TNBC in a mouse model. Treatment with 3f every other day signicantly reduced the numbers of lung tumor nodules in BALB/c nude mice in a dose-dependent manner at 6 weeks post inoculation (Fig. 6a  and c) . All of the mice receiving 3f at 2 or 4 mg kg À1 survived with an obvious gain in body weights while only 5 mice in the control group (n ¼ 8) receiving vehicle treatment survived and they signicantly lost their body weights ( Fig. 6b and d) . Such data clearly demonstrated that treatment with 3f inhibited the lung metastasis of TNBC in mice.
To examine whether 3f could inhibit the production of TNBC cell-derived MVs, budding MVs at the MDA-MB-231 cell surface were directly imaged by immunouorescence. MDA-MB-231 (Fig. 7a) . Given that the focal adhesion (FAs) can stimulate cell motility that is required for the invasion and metastasis of cancer cells, 4 we further investigated the effect of 3f on the MV-mediated FAs by immunouorescence. MDA-MB-231 cells were pre-treated with, or without, carboxy-PTIO for 1 h and then treated with 3f. Their supernatants containing the shed MVs were collected and used to stimulate the formation of FAs in MDA-MB-231 cells. Following staining with Alexa Fluor 568-conjugated phalloidin and FITC-anti-vinculin antibody, we observed lower numbers of FAs in the cells that had been treated with the conditional medium from the 3f-treated cells than those in the control cells, which was completely rescued by pretreatment with PTIO (Fig. 7b) . Quantitative analysis revealed that treatment with 3f signicantly reduced the numbers of FAs and their total areas in (Fig. S12 ‡) . These three independent lines of evidence demonstrated that treatment with 3f signicantly reduced the formation of MVs, dependent on NO production in MDA-MB-231 cells, contributing to the anti-TNBC activity.
A previous study has shown that RAB22A is necessary for the shedding of MVs in TNBC cells. 4 The gene expression can be regulated by epigenetic modications, such as DNA methylation and microRNA regulation. 24 Indeed, the expression of the RAB22A gene can be down-regulated by microRNA-203 (miR-203), but up-regulated by the miR-203 specic inhibitor or hypoxia (1% O 2 ), 4, 25, 26 Accordingly, the shedding MVs are enhanced by RAB22A, but down-regulated by miR-203 in TNBC cells. It is notable that NO as an epigenetic regulator has been reported to upregulate the expression of miR-203. 27 To gain more insights into how NO affects the generation of MVs, we assessed the effect of 3f on the miR-203 and RAB22A expression in MDA-MB-231 cells by quantitative RT-PCR. It was observed that NO produced by 3f treatment increased the relative levels of miR-203 but decreased the levels of RAB22A mRNA transcription in MDA-MB-231 cells (Fig. 8a and b) . The modulatory effects of 3f on the levels of miR-203/RAB22A expression were signicantly mitigated by pre-treatment with carboxy-PTIO or transfection with the miR-203 inhibitor. It was also observed that transfection with the miR-203 specic inhibitor or culture of cells under an extrinsic hypoxia condition (1% O 2 ) signicantly increased the RAB22A transcription. The results were consistent with previous reports. 4, 26 However, the promoting effects by an extrinsic hypoxic condition (1% O 2 ) on the levels of RAB22A transcription were mitigated by treatment with 3f ( Fig. 8a and b) . Such results indicated that high levels of NO produced by 3f treatment lowered the RAB22A transcription by increasing miR-203 expression in MDA-MB-231 cells. Subsequently, we determined the numbers of shedding MVs in the supernatants of cultured cells by purifying the MVs using serial centrifugation and nanoparticle tracking analysis. Firstly, transfection with the miR-203 specic inhibitor or culture of cells under an extrinsic hypoxia condition (1% O 2 ) signicantly increased the numbers of MVs in the supernatants of cultured MDA-MB-231 cells (Fig. 8c) . These results were consistent with a previous report 4 and indicated that the inhibition of endogenous miR-203 enhanced the production of MVs in TNBC cells. However, the promoting formation of MVs in the cells cultured under an extrinsic hypoxic condition (1% O 2 ) was signicantly mitigated by treatment with 3f. Secondly, treatment with 3f signicantly reduced the numbers of MVs in the supernatants of cultured MDA-MB-231 cells, which was almost completely abrogated by pre-treatment with carboxy-PTIO or transfection with the miR-203 specic inhibitor (Fig. 8c) . These results suggest that 3f may inhibit the production of MVs in MDA-MB-231 cells by epigenetic modication of the miR-203/ RAB22A expression in an NO-dependent manner.
Conclusions
In conclusion, we provide the rst evidence of an NO donor acting as an epigenetic modulator of miR-203 and RAB22A expression to inhibit the MV formation, and the proliferation, invasion and metastasis of TNBC. The compounds like 3f may be valuable for the intervention of TNBC or other highly aggressive cancers.
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